Gli1 expression in pancreatic ductal adenocarcinoma and its clinical significance
| Autor: | Yi C, Qin Ry, Wang M, X.Y. Wang, Li Hj, Lin H, Abula Y, Guo Yq |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Male
Pathology medicine.medical_specialty In Vitro Techniques Zinc Finger Protein GLI1 GLI1 Genetics Carcinoma medicine Biomarkers Tumor Humans Clinical significance Molecular Biology Pathological Pancreas Aged Regulation of gene expression integumentary system biology business.industry General Medicine Middle Aged medicine.disease Prognosis Immunohistochemistry digestive system diseases Gene Expression Regulation Neoplastic Pancreatic Neoplasms medicine.anatomical_structure biology.protein Biomarker (medicine) Female Tumor Suppressor Protein p53 business Carcinoma Pancreatic Ductal Transcription Factors |
| Zdroj: | Genetics and molecular research : GMR. 14(4) |
| ISSN: | 1676-5680 |
| Popis: | The aim of this study was to explore the correlation between the expression levels of Gli1 and p53 in pancreatic ductal adenocarcinoma (PDAC) and its pathological significance. Immunohistochemistry (IHC) was employed to measure the expression level of Gli1 and p53 in 85 sets of paraffin-embedded PDAC and corresponding para-carcinoma tissue specimens. The relationship between these results and the respective patients' clinicopathologic parameters was analyzed. IHC staining revealed that the expression levels of Gli1 and p53 in cancer tissues were evidently higher than that of para-carcinoma tissues (P < 0.05); while Gli1 expression levels correlated with the corresponding TNM stage and tumor infiltration depth, p53 expression level correlated with the respective TNM stage (P < 0.05). Taken together, this study demonstrates increased expression of Gli1 and p53 in PDAC, and proves that Gli1 could be apotential biomarker for prognostic judgment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|